CIP2A and medulloblastoma: Prior investigations from our lab found that treatment with the PP2A activator, FTY720, led to decreased CIP2A expression in two of the three medulloblastoma PDXs utilized [13], suggesting the effect of PP2A activation on CIP2A expression may be cell line specific.